Habermann TM - Search Results

1

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, Walker RC, Ansell SM, Macon WR, Gores GG, Stegall MD, McGregor CG. Ghobrial IM, et al. Among authors: habermann tm. J Clin Oncol. 2005 Oct 20;23(30):7574-82. doi: 10.1200/JCO.2005.01.0934. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186599

2

Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990.

Letendre L, Hoagland HC, Moore SB, Chen MG, Gastineau DA, Gertz MA, Habermann TM, Litzow MR, Noël P, Solberg LA Jr, et al. Letendre L, et al. Among authors: habermann tm. Mayo Clin Proc. 1992 Feb;67(2):109-16. doi: 10.1016/s0025-6196(12)61309-3. Mayo Clin Proc. 1992. PMID: 1312187

3

Pretransplantation assessment of the risk of lymphoproliferative disorder.

Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, McGregor CG, Paya CV. Walker RC, et al. Among authors: habermann tm. Clin Infect Dis. 1995 May;20(5):1346-53. doi: 10.1093/clinids/20.5.1346. Clin Infect Dis. 1995. PMID: 7620022

4

Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.

Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG. Walker RC, et al. Among authors: habermann tm. J Heart Lung Transplant. 1995 Mar-Apr;14(2):214-21. J Heart Lung Transplant. 1995. PMID: 7779838

5

Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOM.

Gordon LI, Anderson J, Habermann TM, Winter JN, Glick J, Schilder RJ, Cassileth P. Gordon LI, et al. Among authors: habermann tm. J Clin Oncol. 1996 Apr;14(4):1275-81. doi: 10.1200/JCO.1996.14.4.1275. J Clin Oncol. 1996. PMID: 8648384 Clinical Trial.

6

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.

Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, Inwards DJ, Colgan JP. Ansell SM, et al. Among authors: habermann tm. J Clin Oncol. 1997 Jun;15(6):2296-301. doi: 10.1200/JCO.1997.15.6.2296. J Clin Oncol. 1997. PMID: 9196143

7

Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.

Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG, Ilstrup DM, Wiesner RH, de Groen P, Walker RC, Paya CV. Badley AD, et al. Among authors: habermann tm. Liver Transpl Surg. 1996 Sep;2(5):375-82. doi: 10.1002/lt.500020508. Liver Transpl Surg. 1996. PMID: 9346679 Free article. Clinical Trial.

8

Primary laryngeal lymphoma.

Ansell SM, Habermann TM, Hoyer JD, Strickler JG, Chen MG, McDonald TJ. Ansell SM, et al. Among authors: habermann tm. Laryngoscope. 1997 Nov;107(11 Pt 1):1502-6. doi: 10.1097/00005537-199711000-00014. Laryngoscope. 1997. PMID: 9369397

9

Primary pulmonary lymphoma.

Habermann TM, Ryu JH, Inwards DJ, Kurtin PJ. Habermann TM, et al. Semin Oncol. 1999 Jun;26(3):307-15. Semin Oncol. 1999. PMID: 10375087 Review.

10

Primary thyroid lymphoma.

Ansell SM, Grant CS, Habermann TM. Ansell SM, et al. Among authors: habermann tm. Semin Oncol. 1999 Jun;26(3):316-23. Semin Oncol. 1999. PMID: 10375088 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters